AVR 1.40% $9.86 anteris technologies ltd

Hi iceman.11When the sheep experiment results were announced,...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,599 Posts.
    lightbulb Created with Sketch. 163
    Hi iceman.11
    When the sheep experiment results were announced, they made a comment (in my words) that the results were great and there was the possibility of doing an earlier trial with a human. Correct?
    Could it be possible that somebody put themselves forward to be used as a guinea pig, maybe thought they had nothing to loose.
    After all, the existing TAVR's do still appear to have certain issues. Correct?
    The possible JV partner is waiting for a couple of months to monitor the patients progress.
    If it is successful they put their money on the table?
    You do know for sure that the ADAPT product has been proven for 10yrs plus...and our little valve has been pumping for the equivalent of over 10yrs.
    Admedus appears from what we believe, to be best in class, so if you want to be part of a fantastic TAVR, would you leave it to long?
    I wouldn't.

    Just thinking outside the square...hope I'm right .

    Regards
    Dabru
    Last edited by Dabru: 05/06/19
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$9.86
Change
-0.140(1.40%)
Mkt cap ! $209.4M
Open High Low Value Volume
$10.00 $10.00 $9.65 $69.04K 7.028K

Buyers (Bids)

No. Vol. Price($)
2 60 $10.35
 

Sellers (Offers)

Price($) Vol. No.
$9.62 1 1
View Market Depth
Last trade - 15.59pm 12/11/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.